Circulating Vaccine-derived Poliovirus1,

Slides:

Advertisements

Similar presentations

Complex Functions These derivatives involve embedded composite, product, and quotient rules. The functions f or g must be derived using another rule.

Advertisements

Test practice Multiplication. Multiplication 9x2.

Weekly Polio Update Nigeria March 7, As at March 7, 2014 Nigeria has:- 1 confirmed WPV1 in 1 State compared to 4 cases in 4 States for the same.

Pan American Health Organization World Health Organization Pandemic and Outbreak Communication PAHO/WHO Module 2: IHR Risk communications Capacity: Public.

Module 1 Introduction to the polio endgame rationale and IPV vaccine

Polio Eradication Dr Marvin Hsiao Division of Medical Virology NHLS/UCT/Groote Schuur Hospital.

Flu Prevention Seminar PRESENTED BY STUDENT NAME.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.

Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.

Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.

Epidemiology of Vaccine Preventable diseases in Iran

1 |1 | Countries using and planning to introduce IPV.

Polio Eradication and End Game Strategy

Derivative – Power Rule, Product Rule, Chain Rule, Quotient Rule Unit 4.

Polio Endgame Strategy in India Considerations and Way Forward WHO-India, NPSP 15 March 2012.

1 Polio Strategic Plan India Expert Advisory Group July 2011 Impact & prospects at the half-way point.

Polio Eradication Update, Challenges & Risks World Health Organization 15 March 2012.

Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.

EBOLA. WHAT IS EBOLA? ◊Virus, from fruit bat ◊No vaccine, no cure for the moment ◊2-21 days from infection until symptoms show ◊Symptoms are similar to.

Global Polio Eradication Initiative The 'Intensified Effort' 18 May 2008.

Percentage without a calculator 10% 10%, 20 %, 30% …. 90% 25%, 50% or 75% 33 ⅓ % and 66 ⅔ % 5% 15%, 25%, 35% etc Mixture.

Child Protection Working Group Who Does What Where in CAR + and Nigeria + Emergencies Cécile Marchand & Jean Mège.

The polio endgame and silent circulation: some related research.

Module 1 Introduction to the polio endgame rationale and IPV vaccine

Approaches to modeling, parameter estimation, and policy guidance during the endgame Guillaume Chabot-Couture Philip Eckhoff Mike Famulare Hao Hu Hil Lyons.

Significant Figures Multiplication and Division Modern Chemistry, p

Perspective and Update

Global Polio Eradication: Current Status, Challenges and Future Directions Steven Wassilak, MD Centers for Disease Control and Prevention, Atlanta APHA.

Chain Rules for Functions of Several Variables

Division with negative numbers:

Introduction to the polio endgame rationale and IPV vaccine

Performance of AFP surveillance, 2014

Vaccine-Derived Poliovirus Outbreak Minnesota, 2005

The next phase of polio eradication and the vaccines used

Acute Flaccid Paralysis Surveillance in Ireland

Emerging Diseases Lecture 8: Polio 8.1: Overview

Chapter 3 Derivatives.

Epidemiological Update on Public Health Emergencies

نظام مراقبت فلج شل حاد. نظام مراقبت فلج شل حاد.

The POLIO STORY Kaiqiong Zhao.

المرحلة القادمة من القضاء على شلل الأطفال واللقاحات المستخدمة

بهداشت فردي.

Epidemiological Update on Public Health Emergencies

Applications of the Derivative

Monthly Distribution of Wild Poliovirus Cases1,

Epidemiological Update on Public Health Emergencies

06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Circulating Vaccine-derived Poliovirus*, last 6 months

15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

The next phase of polio eradication and the vaccines used

Monthly Distribution of Wild Poliovirus Cases1,

Preparing for the Switch

24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

No new positives this week

05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.

Key issues in the persistence of poliomyelitis in Nigeria: a case-control study Dr Tara D Mangal, PhD, R Bruce Aylward, MD, Michael Mwanza, BComm, Alex.

16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Polio: Where Are We Now… After 30 Years of Dedication and Hard Work?

Creating an information system for the Global Polio Eradication Initiative IDM 2018 Symposium Paul Chenoweth, WHO (presented by Arie Voorman, BMGF)

27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

2008 Multiple Choice.

Polio Eradication Progress & Challenges.

Multiplication Facts 3 x Table.

The next phase of polio eradication and the vaccines used

Fig. 3 Anticipated transmission dynamics under scenarios of vaccine escape and vaccine waning. Anticipated transmission dynamics under scenarios of vaccine.

Presentation transcript:

Circulating Vaccine-derived Poliovirus1, 2000-2011 1Circulating Vaccine-derived poliovirus (cVDPV) is associated with 2 or more cases of AFP. Niger 2006, Niger 2009, Niger 2010, Chad 2010 cVDPVs are linked to the Nigeria outbreak. VDPV type 2 cases with greater than 5nt difference from sabin in VP1 and VDPV types 1 and 3 cases with greater than 9nt difference from sabin in VP1 are reported here. Figures exclude VDPV from non-AFP source. Nigeria figures include the following cases with WPV1/cVPDV 2 mixture: 2005 – 2, 2006 - 1, 2007 - 1, 2008 – 3, 2009 - 1, 2011 – 1; WPV3/cVPDV2 mixture 2007 - 2. *Figures include multiple emergences and transmission chains.